Similar articles

• Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: association with shifts from nonmetastatic to metastatic cells.

  Katzav S, De Baetselier P, Tartakovsky B, Feldman M, Segal S. Katzav S, et al. J Natl Cancer Inst. 1983 Aug;71(2):317-24. J Natl Cancer Inst. 1983. PMID: 6576189
• Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.

  Mandelboim O, Vadai E, Feldman M, Eisenbach L. Mandelboim O, et al. Gene Ther. 1995 Dec;2(10):757-65. Gene Ther. 1995. PMID: 8750016
• Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.

  Schirrmacher V. Schirrmacher V. Invasion Metastasis. 1981;1(1):4-21. Invasion Metastasis. 1981. PMID: 7188381
• MHC-coded unique alloantigens and antitumor immunity.

  Martin WJ. Martin WJ. Transplant Proc. 1981 Dec;13(4):1837-40. Transplant Proc. 1981. PMID: 7036480 Review. No abstract available.
• The heterogeneous nature of metastatic neoplasms: implications for the treatment of cancer.

  Fidler IJ, Kozlowski JM. Fidler IJ, et al. Urology. 1984 Apr;23(4 Suppl):29-38. doi: 10.1016/s0090-4295(84)80064-3. Urology. 1984. PMID: 6369719 Review. No abstract available.